- Home
- SKYW vs VKTX Comparison
SKYW vs VKTX Comparison
Compare SKYW & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKYW | VKTX |
|---|---|---|
| Founded | 1972 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SKYW | VKTX |
|---|---|---|
| Price | $104.15 | $36.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $124.75 | $87.07 |
| AVG Volume (30 Days) | 264.3K | ★ 2.9M |
| Earning Date | 01-29-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.86 | N/A |
| EPS | ★ 10.47 | N/A |
| Revenue | ★ $3,978,113,000.00 | N/A |
| Revenue This Year | $16.87 | N/A |
| Revenue Next Year | $3.86 | N/A |
| P/E Ratio | $10.11 | ★ N/A |
| Revenue Growth | ★ 19.27 | N/A |
| 52 Week Low | $74.70 | $18.92 |
| 52 Week High | $135.57 | $49.67 |
Technical Indicators
Market Signals| Indicator | SKYW | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | 51.49 |
| Support Level | $102.89 | $36.49 |
| Resistance Level | $108.70 | $38.50 |
| Average True Range (ATR) | 2.84 | 1.85 |
| MACD | 0.66 | -0.04 |
| Stochastic Oscillator | 61.78 | 50.84 |
Price Performance
Historical ComparisonAbout SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.